| Literature DB >> 21716693 |
Noorlidah Abdullah1, Siti Marjiana Ismail, Norhaniza Aminudin, Adawiyah Suriza Shuib, Beng Fye Lau.
Abstract
Considering the importance of diet in prevention of oxidative stress-related diseases including hypertension, this study was undertaken to evaluate the in vitro antioxidant and ACE inhibitory activities of selected culinary-medicinal mushrooms extracted by boiling in water for 30 min. Antioxidant capacity was measured using the following assays: DPPH free radical scavenging activity, β-carotene bleaching, inhibition of lipid peroxidation, reducing power ability, and cupric ion reducing antioxidant capacity (CUPRAC). Antioxidant potential of each mushroom species was calculated based on the average percentages relative to quercetin and summarized as Antioxidant Index (AI). Ganoderma lucidum (30.1%), Schizophyllum commune (27.6%), and Hericium erinaceus (17.7%) showed relatively high AI. Total phenolics in these mushrooms varied between 6.19 to 63.51 mg GAE/g extract. In the ACE inhibitory assay, G. lucidum was shown to be the most potent species (IC(50) = 50 μg/mL). Based on our findings, culinary-medicinal mushrooms can be considered as potential source of dietary antioxidant and ACE inhibitory agents.Entities:
Year: 2011 PMID: 21716693 PMCID: PMC3118607 DOI: 10.1155/2012/464238
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Total phenolic content of culinary-medicinal mushrooms studied.
| Mushroom species | Total phenolic content | |
|---|---|---|
| Scientific name | Common name(s) | (mg GAE/g extract) |
|
| Black poplar mushroom; | 25.40 ± 1.52g |
|
| Jelly mushroom; Judas's ear fungus; | 6.19 ± 0.87a |
|
| Golden needle mushroom; | 16.69 ± 2.62d,e |
|
|
| 63.51 ± 3.11h |
|
| Lion's mane mushroom; | 10.20 ± 2.25a,b |
|
| Forest mushroom, | 14.70 ± 3.01c,d |
|
| Abalone oyster; summer oyster mushroom | 9.26 ± 0.77a,b |
|
| King oyster; king trumpet mushroom; French horn mushroom; | 20.95 ± 2.39f |
|
| Pink oyster mushroom | 20.24 ± 0.68e,f |
|
| White oyster mushroom | 12.24 ± 1.17b,c |
|
| Grey oyster mushroom | 17.70 ± 2.12d,e,f |
|
| Bracket fungus; spilt-gill fungus; | 16.47 ± 0.42d,e |
|
| “Termite nest fungus” | 11.31 ± 0.42b,c |
|
| Paddy straw mushroom; | 20.88 ± 3.13f |
|
| ||
| Positive controls | ||
|
| ||
| Quercetin | 194.24 ± 7.58i | |
| Butylated hydroxyanisole (BHA) | 931.86 ± 49.78k | |
| Ascorbic acid* | 25.40 ± 1.39g | |
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with different lowercase letters (a–k) indicate significant difference at P < .05.
*The value is an estimation of total reducing capacity of ascorbic acid instead of its phenolic content.
Grading of selected culinary-medicinal mushrooms for total antioxidant activity according to the method by Puttaraju et al. [17].
| Relative percentage of each antioxidant capacity assay | ||||||
|---|---|---|---|---|---|---|
| Mushroom species/positive controls | DPPH |
| ILP | RPA | CUPRAC | Average of total antioxidant activity (Relative percentage = antioxidant index) |
| (1) Quercetin | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| (2) BHA | 30.5 | 67.4 | 86.0 | 96.0 | 92.8 | 74.5 |
| (3) Ascorbic acid | 41.6 | 16.2 | 93.0 | 95.0 | 84.9 | 66.2 |
| (4) | 0.6 | 23.4 | 65.5 | 10.8 | 50.1 | 30.1 |
| (5) | 0.1 | 84.1 | 41.5 | 0.9 | 11.6 | 27.6 |
| (6) | 0.2 | 15.5 | 57.3 | 3.2 | 15.5 | 18.4 |
| (7) | 0.1 | 21.2 | 54.4 | 0.9 | 12.0 | 17.7 |
| (8) | 0.2 | 10.4 | 57.2 | 4.7 | 14.4 | 17.4 |
| (9) | 0.1 | 6.7 | 64.6 | 2.4 | 10.8 | 16.9 |
| (10) | 0.2 | 7.4 | 64.8 | 2.8 | 7.8 | 16.6 |
| (11) | 0.1 | 14.6 | 53.0 | 5.5 | 8.7 | 16.4 |
| (12) | 0.2 | 22.4 | 43.8 | 1.4 | 11.8 | 15.9 |
| (13) | 0.2 | 7.5 | 54.8 | 2.3 | 13.0 | 15.6 |
| (14) | 0.3 | 14.4 | 38.2 | 3.4 | 18.8 | 15.0 |
| (15) | 0.1 | 10.6 | 49.2 | 3.2 | 9.9 | 14.6 |
| (16) | 0.1 | 7.1 | 57.0 | 1.6 | 7.1 | 14.6 |
| (17) | 0.1 | 4.8 | 47.7 | 0.7 | 6.5 | 12.0 |
The average of DPPH (free radical scavenging activity), β-CB (β-carotene bleaching assay), ILP (inhibition of lipid peroxidation), RPA (reducing power ability), and CUPRAC (cupric ion reducing antioxidant capacity) of quercetin is based on 100. Antioxidant potential (average of total antioxidant activity) of other positive controls and mushrooms studied was expressed as average relative percentages compared to quercetin.
Antioxidant capacities of selected culinary-medicinal mushrooms as determined by the DPPH free radical scavenging activity, inhibition of lipid peroxidation using buffered egg yolk and β-carotene bleaching assays.
| DPPH free radical scavenging activity |
| Lipid peroxidation | |
|---|---|---|---|
| Mushroom species | IC50 (mg/mL) | IC50 (mg/mL) | Percentage of inhibition at 10 mg/mL |
|
| 9.559 ± 0.462a,b,c | 12.95 ± 0.842e | 33.33 ± 18.14a |
|
| 23.916 ± 0.106d,e,f | 27.82 ± 0.498g | 56.41 ± 2.74c,d |
|
| 39.050 ± 5.717h | 38.80 ± 0.039h | 41.71 ± 4.23a,b,c |
|
| 5.280 ± 0.263a,b | 7.94 ± 0.783b,c | 57.18 ± 14.05d |
|
| 25.471 ± 0.039c,d,e | 8.76 ± 1.567b | 47.52 ± 4.87a,b,c,d |
|
| 19.093 ± 0.296c,d,e | 8.33 ± 0.020b,c,d | 38.29 ± 4.16a,b |
|
| 31.500 ± 0.053f,g,h | 26.08 ± 2.383g | 49.83 ± 4.3b,c,d |
|
| 15.422 ± 0.037b,c,d | 24.71 ± 0.542g | 47.86 ± 9.22a,b,c,d |
|
| 17.857 ± 0.000c,d,e | 11.97 ± 0.317d,e | 50.09 ± 6.07b,c,d |
|
| 21.233 ± 0.045d,e,f | 25.08 ± 0.333g | 56.58 ± 7.43c,d |
|
| 23.100 ± 0.156d,e,f | 17.50 ± 0.012f | 42.99 ± 3.34a,b,c,d |
|
| 35.659 ± 0.055g,h | 2.21 ± 0.237a | 36.24 ± 9.41a,b |
|
| 26.839 ± 0.189e,f,g | 12.79 ± 0.381e | 46.32 ± 2.73a,b,c,d |
|
| 17.832 ± 0.020c,d,e | 17.92 ± 0.197f | 50.00 ± 1.47b,c,d |
|
| |||
| Positive controls | |||
|
| |||
| Quercetin | 0.032 ± 0.007a | 1.86 ± 0.014a | 87.35 ± 6.11e |
| Butylated hydroxyanisole (BHA) | 0.097 ± 0.012c | 2.76 ± 0.014a | 75.13 ± 2.02e |
| Ascorbic acid | 0.078 ± 0.005b | 11.50 ± 0.135c,d,e | 81.54 ± 1.09e |
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with different lowercase letters (a–h) indicate significant difference at P < .05.
Reducing power of selected culinary-medicinal mushrooms.
| Mushroom species | Absorbance values (at 700 nm) of mushroom extracts of different concentrations (mg/mL) | |||
|---|---|---|---|---|
| 0.05 | 0.10 | 0.50 | 1.00 | |
|
| 0.060 ± 0.013c | 0.054 ± 0.014d,e | 0.084 ± 0.007a,b | 0.193 ± 0.002e |
|
| 0.035 ± 0.010a,b,c | 0.032 ± 0.003b,c,d,e | 0.061 ± 0.005a,b | 0.110 ± 0.008b,c |
|
| 0.011 ± 0.007a | 0.011 ± 0.007a | 0.017 ± 0.006a | 0.056 ± 0.022a |
|
| 0.029 ± 0.009a,b,c | 0.063 ± 0.000e | 0.270 ± 0.007c | 0.453 ± 0.046f |
|
| 0.017 ± 0.005a,b,c | 0.030 ± 0.022b,c,d | 0.023 ± 0.009a | 0.077 ± 0.019a,b |
|
| 0.024 ± 0.050a,b,c | 0.017 ± 0.011a,b,c | 0.036 ± 0.003a,b | 0.073 ± 0.014a,b |
|
| 0.021 ± 0.006a,b,c | 0.029 ± 0.010b,c,d | 0.040 ± 0.009a,b | 0.043 ± 0.009a |
|
| 0.003 ± 0.013a,b | 0.012 ± 0.027a,b | 0.058 ± 0.003a,b | 0.165 ± 0.041d,e |
|
| 0.031 ± 0.013a,b,c | 0.044 ± 0.013c,d,e | 0.080 ± 0.018a,b | 0.151 ± 0.026c,d,e |
|
| 0.035 ± 0.040a,b,c | 0.053 ± 0.009d,e | 0.070 ± 0.022a,b | 0.110 ± 0.007b,c |
|
| 0.037 ± 0.044b,c | 0.034 ± 0.027b,c,d,e | 0.081 ± 0.026a,b | 0.144 ± 0.030c,d |
|
| 0.018 ± 0.002c | 0.021 ± 0.003d,e | 0.023 ± 0.004a,b | 0.490 ± 0.017g |
|
| 0.029 ± 0.010a,b,c | 0.047 ± 0.024c,d,e | 0.138 ± 0.038b | 0.193 ± 0.019d,e |
|
| 0.043 ± 0.008b,c | 0.045 ± 0.016c,d,e | 0.117 ± 0.006a,b | 0.170 ± 0.003d,e |
|
| ||||
| Positive controls* | ||||
|
| ||||
| Quercetin | 2.506 ± 0.054e | |||
| Butylated hydroxyanisole (BHA) | 2.405 ± 0.033d,e | |||
| Ascorbic acid | 2.380 ± 0.197d | |||
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with different lower case letters (a–g) indicate significant difference at P < .05.
*Absorbance values for positive controls were measured at the concentration of 0.50 mg/mL.
CUPRAC of selected culinary-medicinal mushrooms.
| Mushroom species | Absorbance values (at 450 nm) of mushroom extracts of different concentrations (mg/mL) | ||||
|---|---|---|---|---|---|
| 0.10 | 0.50 | 1.00 | 5.00 | 10.00 | |
|
| 0.105 ± 0.022a,b | 0.396 ± 0.039a | 0.469 ± 0.095b,c | 2.318 ± 0.047e | 2.778 ± 0.015g |
|
| 0.242 ± 0.040d | 0.227 ± 0.022a | 1.105 ± 0.044e | 1.401 ± 0.312b,c | 1.739 ± 0.222a |
|
| 0.063 ± 0.024a | 0.137 ± 0.015a | 0.318 ± 0.019a,b | 1.173 ± 0.034a,b | 1.958 ± 0.037b |
|
| 0.519 ± 0.020e | 1.058 ± 0.103b | 1.740 ± 0.181f | 2.802 ± 0.046f | 2.959 ± 0.000h |
|
| 0.173 ± 0.050b,c,d | 0.253 ± 0.050a | 0.548 ± 0.056c | 1.422 ± 0.065b,c | 2.442 ± 0.120d,e |
|
| 0.155 ± 0.046b,c | 0.249 ± 0.038a | 0.561 ± 0.023c | 1.686 ± 0.044c,d | 2.578 ± 0.018e,f |
|
| 0.185 ± 0.083c,d | 0.150 ± 0.029a | 0.487 ± 0.045b,c | 1.435 ± 0.187b,c | 2.144 ± 0.132c |
|
| 0.125 ± 0.017a,b,c | 0.275 ± 0.013a | 0.458 ± 0.056b,c | 1.967 ± 0.034d,e | 2.657 ± 0.074f,g |
|
| 0.146 ± 0.015b,c | 0.328 ± 0.021a | 0.530 ± 0.060c | 1.574 ± 0.082c | 2.467 ± 0.071d,e |
|
| 0.070 ± 0.027a | 0.165 ± 0.012a | 0.390 ± 0.072a,b,c | 1.395 ± 0.129b,c | 2.345 ± 0.056d |
|
| 0.183 ± 0.026c,d | 0.208 ± 0.031a | 0.444 ± 0.041b,c | 1.520 ± 0.029b,c | 2.427 ± 0.018d,e |
|
| 0.114 ± 0.009a,b,c | 0.244 ± 0.046a | 0.832 ± 0.214d | 1.476 ± 0.061b,c | 2.060 ± 0.031b,c |
|
| 0.127 ± 0.014a,b,c | 0.184 ± 0.013a | 0.250 ± 0.048a | 0.819 ± 0.456a | 2.378 ± 0.066d |
|
| 0.165 ± 0.031b,c | 0.303 ± 0.041a | 0.831 ± 0.078d | 2.028 ± 0.212d,e | 2.788 ± 0.015g,h |
|
| |||||
| Positive controls* | |||||
|
| |||||
| Quercetin | 2.110 ± 0.227d | ||||
| Butylated hydroxyanisole (BHA) | 1.958 ± 0.470c,d | ||||
| Ascorbic acid | 1.791 ± 0.220c | ||||
Values were expressed as mean ± standard deviation of three replicate determinations.
Mean values in a column with different lowercase lower case letters (a–h) indicate significant difference at P < .05.
*Absorbance values for positive controls were measured at the concentration of 0.50 mg/mL.
ACE inhibitory activity of selected culinary-medicinal mushrooms.
| Mushroom species | ACE inhibitory activity |
|---|---|
| IC50 (mg/mL) | |
|
| 0.890 ± 0.046 |
|
| 0.510 ± 0.018 |
|
| 0.050 ± 0.009 |
|
| 0.580 ± 0.023 |
|
| 0.054 ± 0.002 |
|
| 0.067 ± 0.026 |
|
| 0.058 ± 0.002 |
|
| 0.050 ± 0.013 |
|
| 0.056 ± 0.012 |
|
| 0.320 ± 0.070 |
|
| 0.760 ± 0.023 |
IC50 values were interpolated from dose-response curve for ACE inhibition of each mushroom species. Values were expressed as mean ± standard deviation of three replicate determinations.